Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) shares fell 9.2% during mid-day trading on Monday . The stock traded as low as $21.45 and last traded at $21.45. 971 shares were traded during mid-day trading, an increase of 47% from the average session volume of 661 shares. The stock had previously closed at $23.63.
Shionogi & Co., Ltd. Trading Down 9.2%
The firm has a 50-day moving average price of $21.29 and a two-hundred day moving average price of $18.38.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
See Also
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
